<DOC>
	<DOCNO>NCT01660867</DOCNO>
	<brief_summary>This prospective , randomize , control , double-blinded , clinical trial Subject : 3mo ~ 24mo . age infant bronchiolitis The effect 3 % NaCl nebulizer dexamethasone admission rate infant ED .</brief_summary>
	<brief_title>Nebulized 3 % Hypertonic Saline Treatment Acute Bronchiolitis Emergency Department</brief_title>
	<detailed_description>Randomly assign one three group - Group I : nebulized epinephrine + 0.9 % saline + placebo - Group II : nebulized epinephrine + 3 % saline + placebo - Group III : nebulized epinephrine + 0.9 % saline + dexamethasone Group I receive two treatment nebulized epinephrine mixed 0.9 % saline total six oral dos placebo , group II receive nebulized epinephrine mixed 3 % saline oral placebo , group III receive nebulized epinephrine mixed 0.9 % saline oral dexamethasone . The primary outcome hospital admission within 7 day day enrollment</detailed_description>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>3mo ~ 24mo aged patient bronchiolitis visit emergency department RDAI score 415 &lt; 3mo , &gt; 24mo infant receive oral inhaled corticosteroid precede 2 week infants previous episode wheeze diagnosis asthma chronic cardiopulmonary disease immunodeficiency infant need intubation infant previous history apnea intubation infant side effect dexamethasone infant bear less 37 week gestation correct age le 6 week presentation</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>hospital admission within 7 day 3 % NaCl nebulizer v dexamethasone</keyword>
</DOC>